Drugs / DW1807-R2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07168473 | Sep 2024 → Aug 2026 overdue | perennial allergic rhinitis | Daewon Pharmaceutical Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DW1807-R2 | “DW1807-R2 Once daily with water regardless of meals without chewing or crushing for up to 4 weeks” NCT07168473 ↗ |